No Longer Overlooked
February 26, 2021
Even if a disease is “rare,” treatment options should not be equally thin on the ground
1 min read

February 26, 2021
Even if a disease is “rare,” treatment options should not be equally thin on the ground
1 min read
February 20, 2021
Cell and gene therapy manufacturing technologies and methods are advancing rapidly, but can regulators keep up? Given the uniqueness of each product, what will it take to make high standards and best practices a reality across the board?
1 min read
February 19, 2021
US Army combat veteran Luis Alvarez has developed a new drug delivery technology that can convert any recombinant protein into a material-binding variant. Here, we find out how the tech can help coat implants and enable long-term local delivery.
1 min read
February 18, 2021
A series of setbacks in the development of an effective treatment for nonalcoholic steatohepatitis has earned the field a reputation for being “plagued” but new approaches are underway
1 min read
February 11, 2021
Vaccine development for COVID-19 may have been rapid, but no one has scrimped on safety. Increased speed is the result of pooled resources, funds, and expertise.
1 min read
February 10, 2021
Small-molecule Sb9 inhibitor targets both cancer and associated cells to suppress tumor growth in mice
1 min read
February 10, 2021
In this eBook, thought leaders from Cambrex discuss market opportunities, drug development challenges, and more.
1 min read
February 9, 2021
Speed and efficiency are everything in pharmaceutical synthesis – and that’s why biocatalysis is an increasingly attractive option
1 min read
February 9, 2021
Pharma hasn’t always covered itself in glory – but as the world scrambles for viable COVID-19 interventions, it has a rare opportunity to rebrand
1 min read
February 8, 2021
How to get macromolecules across the intestinal epithelial barrier
1 min read
False
False